Sarah Cannon
September 10, 2020
Dr. Howard A. “Skip” Burris III Named Advocacy Champion by the Association...

Advocacy Champions are ASCO volunteers who have made meaningful contributions to ASCO’s advocacy activities throughout the year to ensure that...

Read More
Sarah Cannon
August 27, 2020
Sarah Cannon & Lyell Immunopharma Announce Collaboration to Advance Development...

This partnership brings together Lyell’s research and development of cell-based immunotherapies and Sarah Cannon’s expertise in designing and...

Read More
Sarah Cannon
June 15, 2020
American Oncology Network & Sarah Cannon Research Institute Announce Cancer...

Through the partnership, AON and Sarah Cannon will offer clinical trial options to patients across several locations within AON’s network of ...

Read More
Sarah Cannon
May 28, 2020
Sarah Cannon to Present Latest Cancer Research Insights at ASCO®20 Virtual...

More Than 110 Abstracts and Presentations will be Presented by Sarah Cannon Researchers; Dr. Howard A. “Skip” Burris III Serves as ASCO® President...

Read More
Sarah Cannon
May 22, 2020
Daiichi Sankyo Initiates Clinical Trial with 5th DXd ADC, DS-6157, in ...

The first patient has been dosed in a first-in-human phase 1 study evaluating DS-6157, an investigational GPR20 directed antibody drug conjugate...

Read More
Sarah Cannon
April 24, 2020
HCA Healthcare Joins COVID-19 Convalescent Plasma Study

Recovered COVID-19 patients can donate plasma to potentially help critically-ill patients

Read More